Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Ding GR et al. | 2000 | intact cell/cell culture, MO54 cells (derived from a human malignant glioma) | magnetic field, 50/60 Hz, co-exposure | 5 mT |
| Ding GR et al. | 2002 | intact cell/cell culture, MO54 cells (derived from a human malignant glioma) | magnetic field, 50/60 Hz, co-exposure | 5 mT |
| Somosy Z et al. | 2004 | intact cell/cell culture, Madin-Darby canine kidney (MDCK) cells | magnetic field, 50/60 Hz | 500 µT |
| Uckun FM et al. | 1995 | intact cell/cell culture, NALM-6 cells (B cell precursor leukemia cells) | magnetic field, 50/60 Hz | 100 µT |
| Martínez MA et al. | 2021 | intact cell/cell culture, NB69 cells (human neuroblastoma cells) | 50/60 Hz, magnetic field | 100 µT |
| Martínez MA et al. | 2022 | intact cell/cell culture, NB69 cells (human neuroblastoma cells) | 50/60 Hz, magnetic field | - |
| Campbell-Beachler M et al. | 1998 | intact cell/cell culture, PC-12 cells (pheochromocytoma cell line from rat adrenal gland) | magnetic field, 50/60 Hz, co-exposure | 12.5–100 µT |
| Wang Z et al. | 2024 | intact cell/cell culture, RSC96 cells, animal, rat/Sprague Dawley | 50/60 Hz, magnetic field, signals/pulses, also other exposures without EMF, co-exposure | - |
| Kanitz MH et al. | 2007 | intact cell/cell culture, SF767 (human glioma cell line) | magnetic field, 50/60 Hz, electrotherapy, therapeutic/medical device | 1.2 µT |
| Savage Jr RE et al. | 2005 | intact cell/cell culture, SF767 (human glioma cell line) | magnetic field, low frequency, 50/60 Hz | 1.2 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
